Foundation Medicine, Eisai in genetic profiling deal

Foundation Medicine Inc. (Cambridge, Mass.) will conduct genomic profiling in an international clinical trial of an undisclosed cancer candidate from Eisai Co. Ltd. (Tokyo:4523; Osaka:4523). Foundatio...